Takeda to Expand Presence in Asia with Operations in South Korea
The South Korean pharmaceutical market is the 15th largest in the world with an almost 10 percent growth rate projected for the next several years, according to IMS data. With more than 48 million people, South Korea is one of the largest pharmaceutical markets in which Takeda does not have a direct presence and a key market for Takeda’s Asian strategy. Takeda’s expansion into Korea will increase the value of Takeda’s portfolio, address a sizeable territory coverage gap and strengthen Takeda’s reputation in Asia.
The new subsidiary will conduct sales and marketing of key products for the Korean market. Upon establishment, Takeda will build the infrastructure necessary to support further growth of the organization.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.